AVELUMAB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where AVELUMAB was used for Prostate cancer.
Most Reported Side Effects for AVELUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 361 | 9.9% | 361 | 35 |
| Disease progression | 355 | 9.8% | 207 | 65 |
| Off label use | 200 | 5.5% | 56 | 55 |
| Diarrhoea | 153 | 4.2% | 17 | 84 |
| Infusion related reaction | 142 | 3.9% | 14 | 51 |
| Pyrexia | 129 | 3.6% | 18 | 90 |
| Fatigue | 124 | 3.4% | 19 | 36 |
| Neoplasm progression | 119 | 3.3% | 69 | 29 |
| Dyspnoea | 100 | 2.8% | 15 | 66 |
| Nausea | 99 | 2.7% | 15 | 50 |
| Chills | 98 | 2.7% | 6 | 37 |
| Interstitial lung disease | 96 | 2.6% | 19 | 46 |
| Hypertension | 89 | 2.5% | 6 | 35 |
| Rash | 83 | 2.3% | 7 | 24 |
| Acute kidney injury | 82 | 2.3% | 14 | 67 |
Other Indications for AVELUMAB
Transitional cell carcinoma (554)
Product used for unknown indication (439)
Neuroendocrine carcinoma of the skin (401)
Renal cell carcinoma (316)
Metastatic renal cell carcinoma (170)
Bladder cancer (167)
Transitional cell carcinoma metastatic (144)
Non-small cell lung cancer (132)
Bladder transitional cell carcinoma (104)
Neoplasm malignant (90)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)